Incyte Corp. reported an insider equity-compensation transaction for Tray Thomas, reflecting grants made on July 16, 2026 and disclosed on a Form 4 filed July 20, 2026. The filing describes an award of restricted stock units, or RSUs, tied to Incyte common stock. The RSUs will vest 25% per year over four years and may be settled only in shares of Incyte common stock on a one-for-one basis. Including the July 16, 2026 grant, Thomas is reported as having an aggregate of 13,070 shares of common stock issuable under previously reported RSUs that have not yet vested. The report also notes a July 16, 2026 stock option grant. Those options become exercisable in 37 installments: the first 25% vest after one year, and the remaining portion vests monthly over the following three years. The provided filing text does not specify the number of options granted, the exercise price, or the total beneficial ownership after the transactions. No open-market purchase or sale is described in the provided document text. Instead, the filing appears to report routine insider equity awards as part of compensation, involving RSUs and options with multi-year vesting schedules. The transaction codes, per-security share counts for the new grants, and prices are not included in the supplied excerpt. The filing was signed on Thomas’s behalf by Elizabeth Feeney as attorney-in-fact on July 20, 2026.
Stock detail
Incyte (INCY) stock price, chart, and key data
View Incyte stock price, chart movement, and headline metrics on Woodstock's stock detail page.

Stock detail
Incyte
INCY · XNAS
-$2.01 (-1.74%) past day
$113.76
Overnight $112.75 (-0.89%)
Key metrics
Financials
Quarterly revenue, profitability, and balance-sheet snapshot
Operating income & Operating cash flow
Quarterly revenue, profitability, and balance-sheet snapshot
Total assets & Total liabilities
Quarterly revenue, profitability, and balance-sheet snapshot
Total equity & Shares outstanding
Quarterly revenue, profitability, and balance-sheet snapshot
Day range
$115.00 - $118.83
52-week range
$67.27 - $119.60
Close price
$116.69
Market cap
$23.3B
P/E ratio
16.07
Beta
0.76
Financials
FY2026 Q1Operating income
$325M
Operating cash flow
$369M
EPS
1.47
Shares outstanding
199.8M
Total assets
$7B
Total equity
$6B
Total liabilities
$2B
About the company
Incyte Genomics Inc
Incyte Corporation is an American multinational pharmaceutical company with headquarters in Wilmington, Delaware. The company currently operates manufacturing and R&D locations in North America, Europe, and Asia. Incyte Corporation currently develops and manufactures prescription biopharmaceutical medications in multiple therapeutic areas including oncology, inflammation, and autoimmunity.
Analyst rating summary
A current read on analyst sentiment from the insight feed.
Mean target
$117
11
Hold
/ 20
Recent calls
07/20/2026
Goldman Sachs
Salveen Richter
Hold · Price target $110
07/20/2026
William Blair
Matt Phipps
Hold
07/21/2026
H.C. Wainwright
Mitchell Kapoor
Buy · Price target $140
Ticker holders
Review politician disclosures and insider transactions in tabs.
Holder directory
Select a heading to reorder by name, activity date, buy/sell, or displayed value.
#1Ro Khanna
democrat · House · CA-17
- Sell$1,000 / $8,000 / $15,000
- Sell$1,000 / $8,000 / $15,000
- Sell$1,000 / $8,000 / $15,000
- Sell$1,000 / $8,000 / $15,000
- Buy$1,000 / $8,000 / $15,000
- Sell$1,000 / $8,000 / $15,000
#2Ro Khanna
democrat · House · CA-17
- Buy$1,000 / $8,000 / $15,000
- Buy$1,000 / $8,000 / $15,000
#3Rob Bresnahan
republican · House · PA-8
- Sell$1,001 / $8,001 / $15,000
#4Ro Khanna
democrat · House · CA-17
- Buy$1,000 / $8,000 / $15,000
#5Donald J Trump
republican · Executive
Market action
A concise summary of the latest filing, transaction, or market-moving item.
24/5 Trading
Act on the stock when the timing works for you.
With Woodstock, you can move from chart review to order placement in one flow. Trade eligible US stocks 24/5, even outside regular market hours.
*24-hour trading is available except during system maintenance. Some stocks are not eligible for extended-hours trading.
Download the app